Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

pembrolizumab 26 Gemcitabine 20 Cisplatin 12 Nivolumab 11 Carboplatin 8 Paclitaxel 7 Docetaxel 7 atezolizumab 6 durvalumab 5 Radiotherapy 5 fludarabine 4 enfortumab vedotin 4 Ipilimumab 4 Cyclophosphamide 4 Vorinostat 3 Magnetic Resonance Spectroscopy 3 Fluorouracil 3 Filgrastim 3 Doxorubicin 3 zimberelimab 2 vocimagene amiretrorepvec 2 tremelimumab 2 romidepsin 2 poly ICLC 2 infigratinib 2 erdafitinib 2 cc-486 2 belinostat 2 avelumab 2 amminedichloro(2-methylpyridine)platinum(II) 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Urinary Bladder Neoplasms × Mycobacterium w vaccine × Clear all

NCT00694798 2012-05-03

STCC

Cadila Pharnmaceuticals

Phase 1 Completed

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡